• By Beth Allan, Deanna Kamienski, Amanda Micklus, Steven Muntner, and Maureen Riordan
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in July 2016.
Global Discovery Biosciences licensed Cleveland HeartLab Inc. exclusive rights to distribute its PULS (Protein Unstable Lesion Signature) cardiac test to physicians in the US. (Jul.)
GD Biosciences' PULS is a simple, non-invasive blood test designed to identify individuals with active but currently undetected subclinical coronary...